IMC Chicago’s Qiagen QGEN Stock Holding History

IMC Chicago’s Portfolio QGEN Stock Details QGEN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$223K	Sell	5,704 -12,313	-68%	-$457K	﹤0.01%	5563
2026 Q1	$721K	Buy	+18,017	New	+$853K	﹤0.01%	3618

Other funds holding QGEN

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

IMC Chicago's QGEN Position: Q2 2026 in Review

IMC Chicago reduced its Qiagen (QGEN) stake by 68% in Q2 2026, selling an estimated $457K and leaving 5,704 shares worth $223K. The position accounts for ﹤0.01% of the portfolio, ranked #5563.

IMC Chicago first reported a position in QGEN in Q1 2026 and has held it in 2 quarters since. The position peaked at $721K in Q1 2026. 337 funds tracked by Wall St. Rank hold QGEN as of Q2 2026.

IMC Chicago held 5,704 shares of Qiagen worth $223K as of Q2 2026.
IMC Chicago sold 12,313 Qiagen shares in Q2 2026, an estimated $457K.
Qiagen made up ﹤0.01% of IMC Chicago's portfolio in Q2 2026, its #5563 holding.
IMC Chicago first reported a position in Qiagen in Q1 2026 and has held it in 2 quarters since.
IMC Chicago's Qiagen position peaked at $721K in Q1 2026.
337 funds tracked by Wall St. Rank held Qiagen as of Q2 2026.

Based on IMC Chicago's 13F filing for Q2 2026, filed 6 Aug 2026.